Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
Carmen Criscitiello, Giulia Viale, Giuseppe Curigliano, Aron Goldhirsch European Institute of Oncology, Milano, Italy Abstract: Alteration of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin signaling pathway is key for the growth and survival of...
Enregistré dans:
Auteurs principaux: | , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d5bcc36067914069a34e9071aacf3d50 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|